These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19615490)

  • 1. Tachycardia in hypertension: a saga of progress despite prejudice, confusion, and inertia.
    Julius S
    Prog Cardiovasc Dis; 2009; 52(1):26-30. PubMed ID: 19615490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachycardia: an important determinant of coronary risk in hypertension.
    Julius S; Palatini P; Nesbitt SD
    J Hypertens Suppl; 1998 Jan; 16(1):S9-15. PubMed ID: 9534091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High heart rate as predictor of essential hypertension: the hyperkinetic state, evidence of prediction of hypertension, and hemodynamic transition to full hypertension.
    Tjugen TB; Flaa A; Kjeldsen SE
    Prog Cardiovasc Dis; 2009; 52(1):20-5. PubMed ID: 19615489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of tachycardia with morbidity and mortality: pathophysiological considerations.
    Palatini P; Julius S
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S19-27. PubMed ID: 9321736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate as a risk factor for cardiovascular disease.
    Perret-Guillaume C; Joly L; Benetos A
    Prog Cardiovasc Dis; 2009; 52(1):6-10. PubMed ID: 19615487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress, autonomic hyperactivity and essential hypertension: an enigma.
    Julius S; Johnson EH
    J Hypertens Suppl; 1985 Dec; 3(4):S11-7. PubMed ID: 3868710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic neural activity in hypertension and related diseases.
    Grassi G
    Am J Hypertens; 2010 Oct; 23(10):1052-60. PubMed ID: 20651696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCORE model underestimates cardiovascular risk in hypertensive patients: results of the Polish Hypertension Registry.
    Szyndler A; Kucharska WA; Dubiela-D Browska AE; Olszanecka A; Widecka J; B Czkiewicz MA; Widecka K; Galas GY; Chlebi Ska I; Sakiewicz W; Gaciong Z; Widecka K; Januszewicz A; Kawecka-Jaszcz K; Narkiewicz K;
    Blood Press; 2011 Dec; 20(6):342-7. PubMed ID: 21675828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension.
    Julius S; Palatini P; Kjeldsen SE; Zanchetti A; Weber MA; McInnes GT; Brunner HR; Mancia G; Schork MA; Hua TA; Holzhauer B; Zappe D; Majahalme S; Jamerson K; Koylan N
    Am J Cardiol; 2012 Mar; 109(5):685-92. PubMed ID: 22169130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated heart rate as a predictor of increased cardiovascular morbidity.
    Palatini P
    J Hypertens Suppl; 1999 Aug; 17(3):S3-10. PubMed ID: 10489092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
    Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
    Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension.
    Julius S
    Eur Heart J; 1998 Jun; 19 Suppl F():F14-8. PubMed ID: 9651730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
    Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
    Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and neurohumoral evidence of multifaceted pathophysiology in human hypertension.
    Julius S
    J Cardiovasc Pharmacol; 1990; 15 Suppl 5():S53-8. PubMed ID: 1694932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of the sympathetic nervous system in essential arterial hypertension and organ damage].
    Grassi G; Mancia G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():115S-120S. PubMed ID: 8562257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of 2003 European Society of Hypertension-European Society of Cardiology guidelines for predicting stroke using self-measured blood pressure at home: the Ohasama study.
    Asayama K; Ohkubo T; Kikuya M; Metoki H; Obara T; Hoshi H; Hashimoto J; Totsune K; Satoh H; Imai Y
    Eur Heart J; 2005 Oct; 26(19):2026-31. PubMed ID: 15917279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular haemodynamic response to repeated mental stress in normotensive subjects at genetic risk of hypertension: evidence of enhanced reactivity, blunted adaptation, and delayed recovery.
    Schneider GM; Jacobs DW; Gevirtz RN; O'Connor DT
    J Hum Hypertens; 2003 Dec; 17(12):829-40. PubMed ID: 14704727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension.
    Kuzniar J; Skret A; Piela A; Szmigiel Z; Zaczek T
    Obstet Gynecol; 1985 Oct; 66(4):453-8. PubMed ID: 4047535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic hyperactivity in early stages of hypertension: the Ann Arbor data set.
    Julius S; Schork N; Schork A
    J Cardiovasc Pharmacol; 1988; 12 Suppl 3():S121-9. PubMed ID: 2467097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.